Carcinogen and Anticancer Drug Transport by Mrp2 in Vivo: Studies Using Mrp2 (Abcc2) Knockout MiceMaria L.H. Vlaming, Alfred H. Schinkel, Karin Mohrmann et al.|Journal of Pharmacology and Experimental Therapeutics|2006Cited by 156
P-glycoprotein (P-gp/Abcb1), Abcc2, and Abcc3 Determine the Pharmacokinetics of EtoposideJurjen S. Lagas, Alfred H. Schinkel, Els Wagenaar et al.|Clinical Cancer Research|2009Cited by 95
Multidrug Resistance Protein 2 Is an Important Determinant of Paclitaxel PharmacokineticsJurjen S. Lagas, Alfred H. Schinkel, Olaf van Tellingen et al.|Clinical Cancer Research|2006Cited by 90
Functionally Overlapping Roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the Elimination of Methotrexate and Its Main Toxic Metabolite 7-Hydroxymethotrexate <i>In vivo</i>Maria L.H. Vlaming, Alfred H. Schinkel, Zeliha Pala et al.|Clinical Cancer Research|2009Cited by 84
Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate <i>in vivo</i>Maria L.H. Vlaming, Alfred H. Schinkel, Anita van Esch et al.|Molecular Cancer Therapeutics|2009Cited by 68